Literature DB >> 7085626

Dopamine-derived tetrahydroisoquinolines. Novel inhibitors of dihydropteridine reductase.

R Shen, R V Smith, P J Davis, A Brubaker, C W Abell.   

Abstract

Dopamine-derived tetrahydroisoquinolines, such as 3',4'-deoxynorlaudanosolinecarboxylic acid, higenamine-1-carboxylic acid, higenamine, and salsolinol, inhibit human liver dihydropteridine reductase noncompetitively with Ki values ranging from 1.5 to 90 microM. The enzyme is also inhibited noncompetitively by dopamine (Ki = 6 microM) and aminopterin (Ki = 100 microM) but uncompetitively by phenylpyruvic acid (Ki = 6.5 mM). These alkaloids may alter monoamine metabolism in mammals by inhibiting dihydropteridine reductase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085626

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.

Authors:  J Liptrot; D Holdup; O Phillipson
Journal:  J Neural Transm Gen Sect       Date:  1994

2.  Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.

Authors:  K Suzuki; Y Mizuno; M Yoshida
Journal:  Neurochem Res       Date:  1990-07       Impact factor: 3.996

Review 3.  Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.

Authors:  Magdalena Kurnik-Łucka; Pertti Panula; Andrzej Bugajski; Krzysztof Gil
Journal:  Neurotox Res       Date:  2017-10-23       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.